Loading insider details...
Beta
Latest Form 4 (Sep 11, 2026): Exercise/Conversion of 392,157 IRD shares, $451.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 11, 2026 | Opus Genetics, Inc. (IRD) | Exercise/Conversion | 392,157 | $451.0K |
| Jul 27, 2026 | Opus Genetics, Inc. (IRD) | Sale | 9,475 | $27.9K |
| Apr 27, 2026 | Opus Genetics, Inc. (IRD) | Sale | 9,511 | $49.6K |
| Mar 18, 2026 | Opus Genetics, Inc. (IRD) | Sale | 24,438 | $127.3K |
| Jan 27, 2026 | Opus Genetics, Inc. (IRD) | Grant/Award | 483,639 | n/a |
| Nov 4, 2025 | Opus Genetics, Inc. (IRD) | Tax Withholding | 30,350 | $69.8K |
| Mar 26, 2025 | Opus Genetics, Inc. (IRD) | Grant/Award | 392,157 | n/a |
| Mar 18, 2025 | Opus Genetics, Inc. (IRD) | Grant/Award | 330,697 | n/a |
| Dec 30, 2024 | Opus Genetics, Inc. (IRD) | Purchase | 100,000 | $97.6K |
| Dec 23, 2024 | Opus Genetics, Inc. (IRD) | Grant/Award | 6,200 | n/a |